Clinical trial
Epilepsy in Alzheimer's Disease: Effect on Disease Progression
NCT04131491 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epilepsy in Alzheimer's Disease: Effect on Disease Progression
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 12, 2020
- Completion date
- September 30, 2023
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, mild cognitive impairment